| scholarly article | Q13442814 |
| P2093 | author name string | Deborah Nagle | |
| Nhue L Do | |||
| Vitaliy Y Poylin | |||
| P2860 | cites work | Hyperbaric oxygen therapy for late radiation tissue injury | Q24246614 |
| Application of 10 percent formalin for the treatment of radiation-induced hemorrhagic proctitis | Q28201599 | ||
| Non surgical interventions for late radiation proctitis in patients who have received radical radiotherapy to the pelvis | Q28204192 | ||
| Chronic radiation proctitis | Q30668524 | ||
| Argon beam coagulation for treatment of symptomatic radiation-induced proctitis | Q30670519 | ||
| Argon plasma coagulation is an effective treatment for refractory hemorrhagic radiation proctitis | Q30777981 | ||
| Efficacy and safety of Nd:YAG laser for the treatment of bleeding from radiation proctocolitis | Q30992890 | ||
| Short chained fatty acids and the colon: how do they cause vasodilatation? | Q77590918 | ||
| Prospective evaluation of formalin therapy for radiation proctitis | Q77872297 | ||
| Argon plasma coagulation therapy for hemorrhagic radiation proctosigmoiditis | Q78056915 | ||
| Rectal complications after prostate brachytherapy | Q80867146 | ||
| Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up | Q80876623 | ||
| A phase II study to evaluate WF10 in patients with late hemorrhagic radiation cystitis and proctitis | Q81230456 | ||
| Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study | Q81992777 | ||
| High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients | Q31097302 | ||
| Efficacy and safety of argon plasma coagulation for the treatment of hemorrhagic radiation proctitis. | Q31134601 | ||
| Surgical management of intestinal radiation injury | Q33400198 | ||
| Efficacy and safety of single-session argon plasma coagulation in the management of chronic radiation proctitis | Q33584531 | ||
| Optimization and clinical use of multisegment intensity-modulated radiation therapy for high-dose conformal therapy | Q33589812 | ||
| Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09 | Q33710935 | ||
| Pharmacological countermeasures for the acute radiation syndrome | Q34088968 | ||
| Mechanisms of action of sucralfate | Q34269939 | ||
| Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions | Q34372168 | ||
| Systematic review for non-surgical interventions for the management of late radiation proctitis | Q34728366 | ||
| Metronidazole. A therapeutic review and update | Q34743506 | ||
| Systematic review: charged-particle radiation therapy for cancer | Q35003013 | ||
| A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach | Q35036339 | ||
| Treatment of hemorrhagic radiation proctitis with 4 percent formalin | Q35147751 | ||
| Conservative therapies for hemorrhagic radiation proctitis: a review | Q35604300 | ||
| Radiotherapy for patients with the human immunodeficiency virus: are special precautions necessary? | Q36132370 | ||
| Endoscopic Nd:YAG laser treatment of severe radiation injury of the lower gastrointestinal tract: long-term follow-up | Q36443850 | ||
| Updated clinical practice guidelines for the prevention and treatment of mucositis | Q36712445 | ||
| Colorectal complications of external beam radiation versus brachytherapy for prostate cancer | Q37122430 | ||
| Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management | Q37402652 | ||
| Oral vitamin A enhances the effectiveness of formalin 8% in treating chronic hemorrhagic radiation proctopathy | Q37582175 | ||
| Surgery for radiation injury to the large intestine. Variables influencing outcome | Q39483224 | ||
| Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development | Q40094901 | ||
| Fuel selection in intestinal cells | Q40417852 | ||
| Sulfasalazine. A review of its pharmacological properties and therapeutic efficacy in the treatment of rheumatoid arthritis | Q40432257 | ||
| A prospective, randomized, double-blind, placebo-controlled trial of retinol palmitate (vitamin A) for symptomatic chronic radiation proctopathy. | Q40448564 | ||
| Late effects of radiation therapy on the gastrointestinal tract | Q40505517 | ||
| The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer | Q41648329 | ||
| Effect of a prostaglandin--given rectally for prevention of radiation-induced acute proctitis--on late rectal toxicity. Results of a phase III randomized, placebo-controlled, double-blind study | Q43276195 | ||
| Successful and sustained treatment of chronic radiation proctitis with antioxidant vitamins E and C. | Q43584410 | ||
| Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase III trial--Trans-Tasman Radiation Oncology Group | Q44146815 | ||
| Protective effect of amifostine during fractionated radiotherapy in patients with pelvic carcinomas: results of a randomized trial | Q44493061 | ||
| Sucralfate versus mesalazine versus hydrocortisone in the prevention of acute radiation proctitis during conformal radiotherapy for prostate carcinoma. A randomized study | Q44497942 | ||
| Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer: A double-blind, randomized trial. | Q45133680 | ||
| Sucralfate does not ameliorate acute radiation proctitis: randomised study and meta-analysis | Q46692139 | ||
| Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. | Q51108325 | ||
| Surgical treatment of radiation injuries of the colon and rectum. | Q54148017 | ||
| Radiation-induced proctosigmoiditis | Q57071875 | ||
| Late GI and GU complications in the treatment of prostate cancer | Q60153377 | ||
| Short chain fatty acids are effective in short-term treatment of chronic radiation proctitis | Q60697092 | ||
| Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer | Q62514147 | ||
| Use of radiation with or without WR-2721 in advanced rectal cancer | Q67487926 | ||
| Preliminary results of a phase I/II study of sodium pentosanpolysulfate in the treatment of chronic radiation-induced proctitis | Q67654403 | ||
| Correlation of radiotherapeutic parameters and treatment related morbidity in carcinoma of the prostate--analysis of RTOG study 75-06 | Q68817192 | ||
| A new concept in the treatment of osteoradionecrosis | Q70903526 | ||
| Radiation injury of the rectum: evaluation of surgical treatment | Q70994951 | ||
| Sucralfate | Q71854439 | ||
| Endoluminal formalin therapy for haemorrhagic radiation proctitis | Q72235290 | ||
| Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease | Q72437063 | ||
| Short chain fatty acid and glucose metabolism in isolated pig colonocytes: modulation by NH4+ | Q73206652 | ||
| Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning | Q73486239 | ||
| Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms | Q73515994 | ||
| Short-chain fatty acids in the treatment of radiation proctitis: a randomized, double-blind, placebo-controlled, cross-over pilot trial | Q73689525 | ||
| Metronidazole in the treatment of chronic radiation proctitis: clinical trial | Q74233196 | ||
| High dose combination radiotherapy for the treatment of localized prostate cancer | Q74654426 | ||
| Diverting loop colostomy for the treatment of refractory gastrointestinal bleeding secondary to radiation proctitis | Q77453626 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Radiation proctitis | Q7280363 |
| P304 | page(s) | 917941 | |
| P577 | publication date | 2011-11-17 | |
| P1433 | published in | Gastroenterology research and practice | Q26853898 |
| P1476 | title | Radiation proctitis: current strategies in management | |
| P478 | volume | 2011 |
| Q94063317 | 2018 CUA Abstracts |
| Q48032087 | Antioxidant Supplementation: A Linchpin in Radiation-Induced Enteritis |
| Q48113428 | BCN057 induces intestinal stem cell repair and mitigates radiation-induced intestinal injury |
| Q41984779 | Benign post-radiation rectal stricture treated with endoscopic balloon dilation and intralesional triamcinolone injection |
| Q26741370 | Chronic haemorrhagic radiation proctitis: A review |
| Q26801205 | Chronic radiation proctitis: tricks to prevent and treat |
| Q26765209 | Chronic radiation proctopathy: A practical review of endoscopic treatment |
| Q46393374 | Chronic radiation-induced proctitis: the 4 % formalin application as non-surgical treatment. |
| Q89947390 | Clinical Outcomes of Dose-escalated Radiotherapy for Localised Prostate Cancer: A Single-institution Experience |
| Q38748613 | Differences in the outcomes and complications between elderly and younger uterine cervical cancer patients treated by definitive radiotherapy - A propensity score-matched study |
| Q52599418 | Evaluation of prophylactic and therapeutic effects of ruscogenin on acute radiation proctitis: an experimental rat model. |
| Q40965275 | Increased expression of VEGF and CD31 in postradiation rectal tissue: implications for radiation proctitis |
| Q58563360 | Interleukin-6 signaling blockade exacerbates acute and late injury from focal intestinal irradiation |
| Q92018845 | Late-onset anorectal disease and psychosocial impact in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study |
| Q37587488 | Local advanced rectal cancer perforation in the midst of preoperative chemoradiotherapy: A case report and literature review |
| Q92969050 | Management of radiation-induced proctitis |
| Q24185868 | Non-surgical interventions for late rectal problems (proctopathy) of radiotherapy in people who have received radiotherapy to the pelvis |
| Q38357630 | Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis |
| Q36329095 | Pelvic radiation therapy: Between delight and disaster |
| Q46876686 | Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer |
| Q39171685 | Prophylactic and therapeutic effects of oral budesonide for acute radiation-induced enteritis and colitis in rats |
| Q35642283 | Radiation proctopathy |
| Q47097039 | Radiation-induced rectovaginal fistulas in locally advanced gynaecological malignancies-new patients, old problem? |
| Q28304957 | Radiation-induced small bowel disease: latest developments and clinical guidance |
| Q92237117 | Rectal enema of bupivacaine in cancer patients with tenesmus pain - case series |
| Q37620880 | Restorative resection of radiation rectovaginal fistula can better relieve anorectal symptoms than colostomy only |
| Q37087512 | Treatment of hemorrhagic radiation-induced proctopathy with a 4% formalin application under perianal anesthetic infiltration |
| Q53571306 | Virgin coconut oil supplementation ameliorates cyclophosphamide-induced systemic toxicity in mice. |
Search more.